FGF21 has been reported to attenuate the progression of atherosclerosis, but its impact on endothelial progenitor cells under high oxidative stress is not clear, and no evidence exits about the changes of levels of this cytokine in SLE. This evidence concerns the gene FGF21 and systemic lupus erythematosus.